What? Wow Oh Wow Oh Double Wow. NOW READ THIS!!!!
Post# of 148292
(Total Views: 594)
Posted On: 05/17/2021 5:12:24 PM
Re: MidnightRider #90537
What? Wow Oh Wow Oh Double Wow. NOW READ THIS!!!!
It's one thing to spin facts a little, that can be easy to get away with.
But this statement right here below by the FDA is a BLATANT flat lie.
In the smaller study that CytoDyn conducted in patients with mild-to-moderate COVID-19 disease (CD10), there was no observed effect of the drug on the study’s primary endpoint or on any of the secondary endpoints.
Double Blatant Lie. Not an error or a mistake or just "overlooked"...uh...a typo error?. No Way Amigos.
HERE IS THE FACTUAL TRUTH:
CD10 displayed "Clinical Signficance" for its Primary Endpoint, and "Statistical Significance" for the Secondary Endpoint NEWS2.
Now add CD12 displays 82% reduction in deaths vs SOC at day 14 and our eIND data where 3 and 4 shots were given.
Now look at LL safety and efficacy vs Remdesivir. Oh gosh, the world it truly upside down on right and wrong, truth vs lies.
The FDA has just Double-Triple-Quadrupled Down On Their Criminal Money Over Death Bets. Now when the Philippines or Brazil or India gives grand reports on Compassionate Use of Leronlimab, FDA folks will be scattering to remote islands in the deep Pacific Ocean, IMO.
It's one thing to spin facts a little, that can be easy to get away with.
But this statement right here below by the FDA is a BLATANT flat lie.
In the smaller study that CytoDyn conducted in patients with mild-to-moderate COVID-19 disease (CD10), there was no observed effect of the drug on the study’s primary endpoint or on any of the secondary endpoints.
Double Blatant Lie. Not an error or a mistake or just "overlooked"...uh...a typo error?. No Way Amigos.
HERE IS THE FACTUAL TRUTH:
CD10 displayed "Clinical Signficance" for its Primary Endpoint, and "Statistical Significance" for the Secondary Endpoint NEWS2.
Now add CD12 displays 82% reduction in deaths vs SOC at day 14 and our eIND data where 3 and 4 shots were given.
Now look at LL safety and efficacy vs Remdesivir. Oh gosh, the world it truly upside down on right and wrong, truth vs lies.
The FDA has just Double-Triple-Quadrupled Down On Their Criminal Money Over Death Bets. Now when the Philippines or Brazil or India gives grand reports on Compassionate Use of Leronlimab, FDA folks will be scattering to remote islands in the deep Pacific Ocean, IMO.
(10)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼